drugset / Trial / NCT06337175

Predictors of Post-alteplase Hemorrhagic Transformation of Brain Infarction

NCT06337175

Phase 4 Completed 600 enrolled Kafrelsheikh University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The investigators evaluated whether the characteristics of ischemic stroke patients, door-to-needle time, and stroke risk factors were predictive variables for different subtypes of post-alteplase hemorrhagic transformation of brain infarction.

Timeline

Start
2021-06-01
Primary completion
2023-10-30
Completion
2024-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alteplase Protein / enzyme biologic 0.9 mg/kg Intravenous

Indications